Corrections:
Roche sold CHF1billion (approx 1.14 billion Australian dollars) in the first half of this year compared to GSK sold $304.4 million of Relenza and presold 190 million doses of yet-to-be-available Pandemic Flu Vaccine.
Should read:
Roche sold CHF1billion (approx 1.14 billion Australian dollars) in the first half of this year compared to GSK sold $638.7 million of Relenza and presold 190 million doses of yet-to-be-available Pandemic Flu Vaccine.
- $1.14 billion of the inferior Tamilu is sold for the first half year compared to $204.4 million of the superior Relenza for the full year and
- Roche is gearing up production capacity to 400 million packs compared to GSK’s 190 million courses.
Should read:
- $1.14 billion of the inferior Tamilu is sold for the first half year compared to $638.7million of the superior Relenza for the full year and
- Roche is gearing up production capacity to 400 million packs compared to GSK’s 190 million courses.
- Forums
- ASX - By Stock
- BTA
- biota - the next csl
biota - the next csl, page-2
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online